Scientists from Kolkata-based Bose Institute have created GlowCas9--a CRISPR protein that lights up while performing gene ...
Gene therapy could be a permanent cure for many life-threatening hereditary diseases, and this will only help in the treatment of genetic diseases and cancer ...
Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike to ...
New gene-editing tools – most notably the Nobel Prize-winning CRISPR-Cas9 – allow targeted tweaks to a crop’s genome, ...
At the height of the COVID-19 pandemic in 2020, Marvin Collins ’22, a bioengineering student, was balancing their Stanford classes from home in Alabama while also helping bioengineering professor ...
CRSP’s main value driver is Casgevy, which was approved for sickle cell disease and β-thalassemia. It’s a one-time ex vivo CRISPR/Cas9 stem‐cell therapy. Unfortunately, Casgevy’s rollout has been slow ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback